Eisai Ltd ADR (ESALY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ESALY | TAK | NBIX | ||
| Company | Eisai Ltd ADR | Takeda Pharmaceutical Ltd ADR | Neurocrine Bioscienc | ||
| Price Information | |||||
| Exchange | OTC US | NYSE | NASDAQ | ||
| Open | 62.5000 | 13.34 | 140.90 | ||
| High | 63.2900 | 13.41 | 141.88 | ||
| Low | 61.0000 | 13.30 | 139.23 | ||
| Last | 61.5100 | 13.37 | 140.71 | ||
| Change | -1.3250 | +0.10 | +0.88 | ||
| % Change | -2.11% | +0.75% | +0.63% | ||
| Volume | 331,801 | 1,333,900 | 616,500 | ||
| 20-Day Average Volume | 58,360 | 1,625,240 | 803,360 | ||
| Previous Close | 62.8350 | 13.27 | 139.83 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 64.1255 | 13.30 | 136.80 | ||
| 20-Day Raw Stochastic | 13.14% | 47.40% | 70.11% | ||
| 20-Day Relative Strength | 42.88% | 44.05% | 54.80% | ||
| Weighted Alpha | +14.94 | -20.15 | +45.16 | ||
| Today's Opinion | 40% Buy | 88% Sell | 88% Buy | ||
| Previous Opinion | 40% Buy | 100% Sell | 88% Buy | ||
| Last Month's Opinion | 64% Buy | 88% Sell | 88% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -6.08% since 01/23/23 | +2.61% since 04/26/24 | +3.47% since 04/26/24 | ||
| Low | 61.0000 on 01/30/23 | 13.08 on 05/01/24 | 136.01 on 05/01/24 | ||
| High | 64.7200 on 01/26/23 | 13.41 on 05/03/24 | 145.22 on 05/01/24 | ||
| 1-Month | |||||
| %Chg | -7.24% since 12/30/22 | -1.18% since 04/03/24 | +2.27% since 04/03/24 | ||
| Low | 60.4000 on 01/05/23 | 13.01 on 04/26/24 | 130.13 on 04/19/24 | ||
| High | 68.8500 on 01/06/23 | 13.77 on 04/08/24 | 145.22 on 05/01/24 | ||
| 3-Month | |||||
| %Chg | +1.67% since 10/28/22 | -6.37% since 02/02/24 | -0.73% since 02/02/24 | ||
| Low | 56.8800 on 11/09/22 | 13.01 on 04/26/24 | 128.00 on 02/07/24 | ||
| High | 73.9035 on 12/05/22 | 14.88 on 02/27/24 | 148.37 on 03/21/24 | ||
| 6-Month | |||||
| %Chg | +34.10% since 07/29/22 | -4.57% since 11/03/23 | +25.14% since 11/03/23 | ||
| Low | 39.1540 on 09/07/22 | 13.01 on 04/26/24 | 103.63 on 11/10/23 | ||
| High | 73.9035 on 12/05/22 | 15.07 on 01/12/24 | 148.37 on 03/21/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 17,638,976 | 42,313,872 | 14,160,632 | ||
| Shares Outstanding, K | 286,766 | 3,164,837 | 100,637 | ||
| Annual Sales | 6,730,410,000 | 29,803,340,000 | 1,887,100,000 | ||
| Annual Net Income | 426,790,000 | 2,345,930,000 | 249,700,000 | ||
| Last Quarter Sales | 1,262,920,000 | 7,556,070,000 | 515,200,000 | ||
| Last Quarter Net Income | 25,840,000 | 718,900,000 | 147,700,000 | ||
| 60-Month Beta | 0.31 | 0.56 | 0.28 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 0.09 on 11/07/22 | 0.51 on 02/01/24 | 0.42 on 05/01/24 | ||
| Latest Earnings Date | 02/02/23 | 05/09/24 | 05/01/24 | ||
| Most Recent Dividend | 0.440 on 09/27/22 | 0.261 on 09/28/23 | N/A | ||
| Next Ex-Dividends Date | 09/27/22 | 09/28/23 | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 72.22 | 6.81 | 38.52 | ||